The key role of the TGFβ/SMAD pathway in fibrogenesis was confirmed in non-neoplastic conditions, cancer-associated fibroblasts [38,42] and in the pathogenesis of both leiomyomas and DFs [1,11]. This evidence concerns the gene TGFB1 and cancer.